Sector ratings Lonza Group AG

Stocks

Market Closed - Swiss Exchange Other stock markets 09:01:09 13/07/2026 pm IST			5-day change	1st Jan Change
588.60 ^CHF	+0.44%		+1.41%	+9.45%

02/07	Nona Biosciences And Lonza Enter Strategic Collaboration To Develop Best-In-Class Single-Domain Antibody-Based BBB-Crossing Technology For CNS Diseases	CI
01/07	Lonza Group AG Expands Strategic Collaboration With Leading US Biopharmaceutical Company	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	5.06TCr		AAA
REVOLUTION MEDICINES, INC.	3.91TCr	-	B	-	-
IQVIA HOLDINGS INC.	3.46TCr		AAA
BEONE MEDICINES AG	3.38TCr		-
CELLTRION, INC.	2.69TCr		A
ASCENDIS PHARMA A/S	1.65TCr	-	-	-	-
MEDPACE HOLDINGS, INC.	1.51TCr		BBB
EUROFINS SCIENTIFIC SE	1.38TCr		AA
ICON PUBLIC LIMITED COMPANY	1.27TCr		AAA
ABIVAX	1.18TCr	-	BBB	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.11TCr		AA
BIO-TECHNE CORPORATION	1.11TCr		AA
TEMPUS AI, INC.	1TCr		A		-
APOGEE THERAPEUTICS, INC.	1TCr	-	B	-	-
KYMERA THERAPEUTICS, INC.	908.12Cr	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	937.87Cr	-	A	-	-
PRAXIS PRECISION MEDICINES, INC.	876.95Cr	-	B	-	-
ALKERMES PLC	864.55Cr		A
QIAGEN N.V.	856.98Cr		AAA
PROTAGONIST THERAPEUTICS, INC.	835.34Cr		BB		-
Average	1.75TCr		A
Weighted average by Cap.			A